Covaxin trials in children between 2-18 years to begin in 10-12 Days: Centre

New Delhi, May 18 (ANI): Niti Aayog Member (Health) Dr. VK Paul on May 18 said that the Phase 2-3 clinical trials of COVID-19 vaccine, Covaxin, which has been approved by the Drugs Controller General of India (DCGI), for in the age group of 2 to 18 years will begin in the next 10-12 days. "COVAXIN has been approved by the Drugs Controller General of India (DCGI), for Phase II/III clinical trials in the age group of 2 to 18 years. I have been told that trials will begin in the next 10-12 days," he said.